1393892-56-2

Basic information

• Product Name: 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid ethyl ester
• Synonyms: 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid ethyl ester
• CAS NO: 1393892-56-2
• Molecular Weight: 233.224
• Mol File: 1393892-56-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid ethyl ester(1393892-56-2)
• EPA Substance Registry System: 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid ethyl ester(1393892-56-2)

Safety Data

• Hazardous Substances Data: 1393892-56-2(Hazardous Substances Data)

Downstream Products

• 1613166-28-1 3-(4-hydroxyphenyl)isoxazole-5-carboxylic acid amide 
• 1613165-73-3 3-[4-(2-trifluoromethylsulfanylbenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-74-4 3-[4-(2-trifluoromethanesulfinylbenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-75-5 3-[4-(2-methoxybenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-76-6 3-[4-(3,4-dimethylbenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-77-7 3-[4-(2-cyanobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-78-8 3-[4-(2,6-dichlorobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-79-9 3-[4-(3,4-difluorobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-80-2 3-[4-(2-fluorobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-81-3 3-[4-(2-methylbenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-82-4 3-[4-(2-trifluoromethoxybenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-83-5 3-[4-(2-iodobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-84-6 3-[4-(2-chloro-6-fluorobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 
• 1613165-85-7 3-[4-(2-chloro-5-fluorobenzyloxy)phenyl]isoxazole-5-carboxylic acid amide 

Relevant articles and documents

SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1)

The invention is concerned with a compound of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compound of formula (I) as well as pharmaceutical compositions containing such compounds. The compound of formula (I) are SCD1 inhibitors and may be useful in treating cancer.